Leukoformula
RU EN
Oncohematology

AML with t(8;21) Translocation: Morphology and Genetics

Diagnostic criteria and morphological features of AML with t(8;21) translocation: blast assessment, granulocyte anomalies, and differential diagnosis with APL.

Светлана Мусина Светлана Мусина 1 min
Presentation slide with the topic of the report on differential diagnosis of AML and APL
Presentation slide with the topic of the report on differential diagnosis of AML and APL
Presentation slide with a list of recurrent cytogenetic abnormalities according to WHO 2017
Presentation slide with a list of recurrent cytogenetic abnormalities according to WHO 2017
Slide with diagnostic criteria for AML and exceptions for blast count in aberrations
Slide with diagnostic criteria for AML and exceptions for blast count in aberrations
Slide with clinical characteristics and prognosis for AML with t(8;21) RUNX1-RUNX1T1
Slide with clinical characteristics and prognosis for AML with t(8;21) RUNX1-RUNX1T1
Slide on heterogeneity and risk factors for relapse in AML with t(8;21)
Slide on heterogeneity and risk factors for relapse in AML with t(8;21)
Slide with a list of morphological features of blasts and granulocytes in AML t(8;21)
Slide with a list of morphological features of blasts and granulocytes in AML t(8;21)
Slide with photomicrographs of bone marrow blast cells in AML with t(8;21)
Slide with photomicrographs of bone marrow blast cells in AML with t(8;21)
Slide with a photomicrograph of the Golgi complex in the cytoplasm of blasts in AML t(8;21)
Slide with a photomicrograph of the Golgi complex in the cytoplasm of blasts in AML t(8;21)
Slide with a photomicrograph of Pelger-Huët anomaly of neutrophils in AML t(8;21)
Slide with a photomicrograph of Pelger-Huët anomaly of neutrophils in AML t(8;21)
Slide with a table of bone marrow and peripheral blood parameters in AML t(8;21)
Slide with a table of bone marrow and peripheral blood parameters in AML t(8;21)

“Differential Diagnosis of AML with Translocation (8;21) from Acute Promyelocytic Leukemia” (Part 1) Valentina Dvirnyk, MD, PhD, Head of the Central Clinical Diagnostic Laboratory, National Research Center for Hematology, Ministry of Health of the Russian Federation V Russian Congress of Laboratory Medicine.

Read next

100%